Alzheimer's Disease Market Research Reports & Industry Analysis
A gradual loss of neurons later in adulthood does not result in significant alteration in brain function during the usual life span. However, the older one gets, the greater the neurologic impairment. Excessive neuronal degeneration in adulthood is called Alzheimer’s disease or senile dementia and is distinguished from the normal changes in aging. Alzheimer’s disease is a progressive disease which results in death of the brain cells causing memory lapses, behavioral issues, and disruption of thinking processes. The disease is considered fatal. Age and generic inheritance are the two key risk factors for developing Alzheimer’s disease. These are also risk factors that are not preventable. However, other preventable risk factors have been linked to the development of AD, including environment, diet, and overall general health. A combination of risk factors is often responsible for the disease.
Alzheimer’s disease is estimated to affect up to 6% of the population over 65. Life expectancy has been increasing around the world due to advances in healthcare, medical research, sanitation, and nutrition. This provides a setting for a higher number of Alzheimer’s disease patients in the future as the population continues to add years to their life.
Alzheimer's Disease Industry Research & Market Reports
-
Global Early Diagnosis Kit For Alzheimer's Disease Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... memory loss. It is the most common cause of dementia, a syndrome characterized by a decline in cognitive function that interferes with daily life. Alzheimer's disease is named after Dr. Alois Alzheimer, who first identified ... Read More
-
China Alzheimer’s Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnostics Technique (Biomarkers, Imaging Techniques), By Type (Triage, Diagnosis), By End Use, And Segment Forecasts, 2024 - 2030
... Growth & Trends The China Alzheimer’s disease diagnostics market size is expected to reach USD 631.73 million by 2030, registering a CAGR of 12.1% from 2024 to 2030, according to a new report by Grand ... Read More
-
Global Alzheimer's Disease Therapeutics and Diagnostics Market Research Report 2024(Status and Outlook)
... time. It is the cause of 60% to 70% of cases of dementia. The Global Alzheimer's Disease Therapeutics and Diagnostics Market Size was estimated at USD 3688.12 million in 2023 and is projected to reach ... Read More
-
Global Alzheimer's Disease Diagnostic Market Research Report 2024(Status and Outlook)
... is the cause of 60% to 70% of cases of dementia. The Global Alzheimer's Disease Diagnostic Market Size was estimated at USD 3688.12 million in 2023 and is projected to reach USD 4032.75 million by ... Read More
-
Global Alzheimer's Disease Treatments Market Research Report 2024(Status and Outlook)
... is the cause of 60% to 70% of cases of dementia. The Global Alzheimer's Disease Treatments Market Size was estimated at USD 3688.12 million in 2023 and is projected to reach USD 4032.75 million by ... Read More
-
Global Alzheimer's Disease Drug Market Research Report 2024(Status and Outlook)
... is the cause of 60% to 70% of cases of dementia. The Global Alzheimer's Disease Drug Market Size was estimated at USD 3684.64 million in 2023 and is projected to reach USD 4028.94 million by ... Read More
-
Blood Brain Barrier Market (3rd Edition): Industry Trends and Global Forecasts, till 2035
... period 2024-2035. The focus of blood-brain barrier drugs and technologies is to address the challenges posed by the selective nature of the blood-brain barrier, enabling therapeutic agents to reach the brain directly. Recent years have ... Read More
-
Global Alzheimer's Disease Market Growth (Status and Outlook) 2024-2030
... downstream market, the Alzheimer's Disease is forecast to a readjusted size of US$ 3943.3 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global ... Read More
-
Alzheimer's Disease Market Insight, Epidemiology And Market Forecast - 2034
... 7MM is expected to increase, driven by better diagnosis and the launch of emerging therapies. DelveInsight’s analysis estimates that among the total diagnosed prevalent cases of Myotonic Dystrophy in 7MM approximately 51% of cases were ... Read More
-
Alzheimer's disease (AD) - Epidemiology Forecast - 2034
... high prevalence underscores the need for innovative treatments to address the rising impact on healthcare systems and patient care. In 2023, among the EU4 and the UK, Germany accounted for the highest diagnosed prevalent cases ... Read More
-
Mild Cognitive Impairment Market Research Report By Disease Type (Amnestic MCI and Non-Amnestic MCI), By Age (Child, Adult, Geriatric), By Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others) By Treatment (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – Industry Forecast Till 2032
... (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – ... Read More
-
Global Alzheimer's Disease Blood Diagnostic Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... in the blood to identify and diagnose Alzheimer's Disease. These diagnostics aim to detect the presence of pathological changes associated with AD, such as amyloid plaques, tau tangles, neurodegeneration, and other related abnormalities, using minimally ... Read More
-
Dementia Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global dementia drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global dementia ... Read More
-
Medical Foods Market Report by Product (Pills, Powder, and Others), Route of Administration (Oral, Enteral), Application (ADHD, Depression, Diabetes, Cancer, Alzheimer's Disease, Metabolic Disorders, and Others), Distribution Channel (Supermarkets, Hospital and Retail Pharmacies, Online Pharmacies, and Others), and Region 2024-2032
... and Others), and Region 2024-2032 The global medical foods market size reached US$ 23.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 36.5 Billion by 2032, exhibiting a growth rate ... Read More
-
Neurological Biomarkers Market Report by Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, and Others), Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), End Use (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, and Others), and Region 2024-2032
... Research Organizations, and Others), and Region 2024-2032 The global neurological biomarkers market size reached US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.0 Billion by 2032, exhibiting a ... Read More
-
GLP-1 Market: Industry Trends and Global Forecasts, till 2035
... Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type of Agonist (Single-agonist, Dual-agonist and Tri-agonist) Route of Administration (Oral and Parenteral), Target indication (Alzheimer’s Disease, ... Read More
-
Global Digital Brain Health Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Region, and Segment Forecasts, 2023 – 2032 Global Digital Brain Health market was valued at US $198.1 Billion in 2022 and is expected to reach ~US $400 Billion by 2032, growing at a CAGR of ... Read More
-
United States Generic Drugs Market Report By Therapeutic Area (Epilepsy, Cancers, Heart Disease, Mental Health, Diabetes, Allergies & Asthama, Chronic Obstructive Pulmonary Diesase, Alzheimer's Disease, HIV/AIDS, Crohn's colitis), Type (Branded Generics, Unbranded Generics), Drug Delivery (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, Medicare D), States and Company analysis 2024-2032
... (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, ... Read More
-
Alzheimer’s Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnostics Technique (Biomarkers, Imaging Techniques), By Type (Triage, Diagnosis), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2024 - 2
... Diagnostics Market Growth & Trends The global Alzheimer’s disease diagnostics market size is expected to reach USD 15.92 billion by 2030, registering a CAGR of 11.4% from 2024 to 2030, according to a new report ... Read More
-
Alzheimer's Drugs Market Report by Drug Class (Cholinesterase Inhibitors NMDA Receptor Antagonist Combination Drugs and Others), Drug Type (Galantamine, Donepezil, Memantine, Rivastigmine, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Region and Company Analysis 2024-2032
... Company Analysis 2024-2032 The global Alzheimer's drug market reached US$ 6.95 Billion in 2023 and is expected to reach US$ 15.08 Billion through 2032, with a CAGR of 8.99 percent from 2024 to 2032. Alzheimer's ... Read More
-
Wearable EEG Headsets Market Size, Share & Trends Analysis Report By Application (Trauma & Surgery, Disease Diagnosis), By Product, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Trends The global wearable EEG headsets market size is expected to reach USD 244.9 million by 2030, growing at a CAGR of 10.47% from 2024 to 2030, according to a new report by Grand View ... Read More
-
Milk Beverage Market Size Outlook, 2024- by Type (Kefir, Butter Milk, Ayran, Others), Categories (Flavored Drink, Unflavored Drink), Distribution channel (Supermarkets, Convenience stores, Online Channels, Others), End User (Adult, Children, Hotels, Others)- Industry Growth, Trends, Opportunities, Share, and Companies Analysis to 2032 Report
... Opportunities, Share, and Companies Analysis to 2032 Report The Milk Beverage market is poised to register a CAGR of 6.15% between 2024 and 2032. The market growth is driven by steady demand and new product ... Read More
-
Neurodegenerative Drugs
... at a CAGR of 4.2% over the analysis period 2023-2030. Multiple Sclerosis Drugs, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$38.3 Billion by the end ... Read More
-
Argentina Alzheimer's Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Argentina market. Also, factors that are driving and restraining the Alzheimer’s drugs market are highlighted in the study. ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... is expected to reach USD 9.78 billion by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029). The emergence of the COVID-19 pandemic impacted the Alzheimer's disease diagnostics and therapeutics market, as ... Read More
Research Assistance
